NASDAQ:LVTX - NL0015000AG6 - Common Stock
Taking everything into account, LVTX scores 3 out of 10 in our fundamental rating. LVTX was compared to 547 industry peers in the Biotechnology industry. The financial health of LVTX is average, but there are quite some concerns on its profitability. LVTX is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -69.12% | ||
ROE | -190.76% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 100% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -4.49 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 6.73 | ||
Quick Ratio | 6.73 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:LVTX (8/29/2025, 2:07:29 PM)
1.57
+0.02 (+1.29%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 3.45 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.6 | ||
P/tB | 1.6 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -69.12% | ||
ROE | -190.76% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 100% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 6.73 | ||
Quick Ratio | 6.73 | ||
Altman-Z | -4.49 |